Vedolizumab to prevent postoperative recurrence of Crohn's disease (REPREVIO): a multicentre, double-blind, randomised, placebo-controlled trial

Geert D’Haens, Carlos Taxonera, Antonio López–Sanromán, Pilar Nos, Silvio Danese, Alessandro Armuzzi, Xavier Roblin, Laurent Peyrin-Biroulet, Rachel West, Wout G.N. Mares, Marjolijn Duijvestein, K Gecse, Brian G. Feagan, Guangyong Zou, Melanie S. Hulshoff, Aart Mookhoek, Lotte Oldenburg, Esmé Clasquin, Yoram Bouhnik, David Laharie